"Leading Pharmaceuticals Company in the USA - ESG Score 27.7" Experience innovative pharmaceutical solutions at Dynavax Technologies Corp., a top player in the pharmaceutical industry based in the United States. With an ESG score of 27.7, we are dedicated to leveraging the power of immune responses for sustainable solutions. Specializing in toll-like receptor stimulation, our cutting-edge products are being investigated for various cancer indications, including HEPLISAV-B vaccine. Discover our novel vaccines and immune modulation technology for enhanced immunity. Join us in shaping the future of pharmaceuticals.